BASF to Develop a High Purity Poloxamer for Mast Therapeutics
Go back to BASF to Develop a High Purity Poloxamer for Mast Therapeutics| MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) | Delayed: 13.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.55 | 52 Week High | $0.71 | |||
| Open | $13.55 | 52 Week Low | $0.07 | |||
| Day High | $13.55 | P/E | N/A | |||
| Day Low | $13.55 | EPS | $-0.35 | |||
| Volume | 1,098,380 | |||||
| MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) | Delayed: 13.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.55 | 52 Week High | $0.71 | |||
| Open | $13.55 | 52 Week Low | $0.07 | |||
| Day High | $13.55 | P/E | N/A | |||
| Day Low | $13.55 | EPS | $-0.35 | |||
| Volume | 1,098,380 | |||||

